⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6

Official Title: A Prospective, Randomized, Open-label Trial Comparing OnDose® AUC Optimized 5-FU Based Administration Versus Standard Body Surface Area (BSA) Dosing in Metastatic Colorectal Cancer Patients (mCRC) Treated With mFOLFOX6

Study ID: NCT01468623

Study Description

Brief Summary: The purpose of this study is to compare OnDose® based pharmacokinetic administration of 5-FU versus standard Body Surface Area (BSA) based administration of 5-FU in patients with metastatic colorectal cancer treated with mFOLFOX6, with or without bevacizumab, to determine if the use of OnDose® achieves an improvement in the Overall Response Rate (ORR) relative to BSA dosing response.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

, Birmingham, Alabama, United States

, Corona, California, United States

, Fountain Valley, California, United States

, La Jolla, California, United States

, Modesto, California, United States

, Rancho Cucamonga, California, United States

, Riverside, California, United States

, Santa Rosa, California, United States

, Washington, District of Columbia, United States

, Merritt Island, Florida, United States

, Ocala, Florida, United States

, Titusville, Florida, United States

, Viera, Florida, United States

, Albany, Georgia, United States

, Chicago, Illinois, United States

, Crystal Lake, Illinois, United States

, Galesburg, Illinois, United States

, Grayslake, Illinois, United States

, Highland Park, Illinois, United States

, Lake Forest, Illinois, United States

, Libertyville, Illinois, United States

, Niles, Illinois, United States

, Skokie, Illinois, United States

, Munster, Indiana, United States

, Louisville, Kentucky, United States

, Baton Rouge, Louisiana, United States

, Metairie, Louisiana, United States

, Ann Arbor, Michigan, United States

, Detroit, Michigan, United States

, Farmington Hills, Michigan, United States

, Great Falls, Montana, United States

, Las Vegas, Nevada, United States

, Hackensack, New Jersey, United States

, Johnson City, New York, United States

, Greensboro, North Carolina, United States

, Fargo, North Dakota, United States

, Minot, North Dakota, United States

, Canton, Ohio, United States

, Columbus, Ohio, United States

, Bend, Oregon, United States

, Drexel Hill, Pennsylvania, United States

, Philadelphia, Pennsylvania, United States

, Crossville, Tennessee, United States

, Huntsville, Tennessee, United States

, Bedford, Texas, United States

, Garland, Texas, United States

, Grapevine, Texas, United States

, Kerrville, Texas, United States

, McAllen, Texas, United States

, San Antonio, Texas, United States

, Tyler, Texas, United States

, Waco, Texas, United States

, Ogden, Utah, United States

, Salt Lake City, Utah, United States

, Fairfax, Virginia, United States

, Newport News, Virginia, United States

, Edmonds, Washington, United States

, Seattle, Washington, United States

Contact Details

Name: Abebe Haregewoin, MD, PhD

Affiliation: Myriad Genetic Laboratories, Inc.

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: